Jing et al. showed similar results in a spinal cord ischemia model, where pretreatment with the CB2r agonist JWH-133 blocked the TLR4 MyD88/NF-κB signaling pathway [113]. This evidence concerns the gene NFKB1 and spinal cord ischemia.